SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,170,488 | +112.5% | 100,400 | +100.8% | 0.23% | +129.3% |
| Q2 2023 | $5,726,000 | -64.4% | 50,000 | -57.2% | 0.10% | -70.8% |
| Q1 2023 | $16,101,163 | +589.2% | 116,819 | +547.9% | 0.34% | +516.4% |
| Q4 2022 | $2,336,327 | -88.3% | 18,030 | -90.0% | 0.06% | -88.2% |
| Q3 2022 | $19,904,000 | +230.7% | 180,060 | +124.2% | 0.47% | +193.7% |
| Q2 2022 | $6,019,000 | +168.7% | 80,300 | +180.0% | 0.16% | +178.9% |
| Q1 2022 | $2,240,000 | +142.4% | 28,678 | +270.0% | 0.06% | +96.6% |
| Q1 2019 | $924,000 | -32.6% | 7,750 | -38.3% | 0.03% | -46.3% |
| Q4 2018 | $1,370,000 | +69.6% | 12,553 | +151.1% | 0.05% | +217.6% |
| Q3 2018 | $808,000 | -32.1% | 5,000 | -44.4% | 0.02% | -41.4% |
| Q2 2018 | $1,190,000 | -72.3% | 9,000 | -87.1% | 0.03% | -80.4% |
| Q3 2016 | $4,299,000 | – | 70,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |